BTG3 and fibrosis: In the ANA(+) group, we found a lower HCV RNA viral load (5.72 log10 IU/ML vs. 6.02 log10 IU/ML; p = 0.06) and higher prevalence of advanced fibrosis (F3 and F4) (38.5% vs. 26.1%; p = 0.098).